查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009011

儿童疫苗市场报告：按类型、技术、应用和地区划分（2026-2034年）

Pediatric Vaccines Market Report by Type (Multivalent, Monovalent), Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, and Others), Application (Infectious Disease, Cancer, Allergy, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2025年全球儿童疫苗市场规模达424亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到751亿美元，2026年至2034年的复合年增长率为6.35%。市场成长的主要驱动因素包括免疫接种计画的扩大、对联合疫苗的日益重视，以及製药公司与医疗机构之间为加速疫苗研发和分发而不断加强的合作。

儿童疫苗是一种刺激免疫系统辨识并对抗特定病原体（例如细菌和病毒）的药物製剂。它们含有减毒或灭活的病原体或其成分，使免疫系统能够建立针对特定疾病的防御机制。儿童疫苗可预防麻疹、脊髓灰质炎、百日咳、肝炎和流感。儿童疫苗在核准使用前均需经过严格的检测和评估，以确保其安全性。它们有助于预防可能导致儿童严重併发症甚至死亡的疾病传播。

目前，儿童中各种感染疾病和潜在危及生命的疾病（例如脊髓灰质炎、结核病和疟疾）的发病率不断上升，正在推动市场成长。此外，全球各国政府不断扩大儿童免疫接种计划，以预防可预防疾病，也促进了市场成长。疫苗储存和分发技术的进步，改善了医疗基础设施欠发达地区的供应链，为市场创造了有利前景。此外，製药公司与医疗机构之间日益增多的合作，加速了疫苗的研发和分发，也为市场成长提供了支持。最后，全球范围内为改善医疗服务而不断增加的诊所和医院建设，也推动了市场成长。

儿童疫苗市场的发展趋势与驱动因素：

扩大免疫接种计划

免疫接种计划的扩展显着推动了儿童疫苗市场的发展。这些由政府和非政府组织支持的免疫接种工作在保护儿童健康和福祉方面发挥着至关重要的作用。随着越来越多的儿童接种针对各种疾病的必要疫苗，儿童疫苗的需求也随之增加。此外，以疾病预防为重点的免疫接种计划正在降低儿童特定疾病的发生率。因此，医疗系统和家庭的负担得以减轻，儿童及其看护者的整体生活品质也得到提升。此外，家长和医护人员对免疫接种重要性的认识不断提高，也促使疫苗接种率不断攀升。

人们越来越关注联合疫苗

人们对联合疫苗日益增长的兴趣推动了儿童疫苗市场的强劲表现。联合疫苗透过在单一製剂中提供对多种疾病的保护，实现了免疫接种的策略性方法。这种方法简化了医护人员、家长和儿童的免疫接种流程，从而提高了免疫接种的依从性和接种率。此外，联合疫苗也解决了疫苗接种犹豫和剂量不足等挑战。儿童只需注射一次即可获得多种疾病的保护，显着减轻了疫苗接种带来的负担。这鼓励家长遵循建议的疫苗接种计划，从而有助于提高全程免疫接种率。

新疫苗研发的扩展

新疫苗研发的加速发展在推动儿童疫苗市场的强劲成长中发挥着至关重要的作用。针对儿童健康需求而研发的新疫苗的出现，有助于加强疾病预防、改善公共卫生状况并扩大市场机会。此外，新疫苗的研发也反映了疫苗技术和研发领域的进步。基因组学和生物资讯学等前沿调查方法使科学家能够更快、更准确地识别潜在的候选疫苗。这种加速的发现速度正在推动高效疫苗的研发，这些疫苗能够适应不断变化的流行病学情况。此外，新疫苗研发活动的增加也促进了公共卫生机构、研究机构和疫苗生产商之间的合作。这些伙伴关係有助于新疫苗的及时推出，并确保有效地分发给儿童群体。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球儿童疫苗市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依类型

  • 多价
  • 一价

第七章 市场区隔：依技术划分

  • 共轭物
  • 减毒活病毒疫苗
  • 失活
  • 次单元
  • 类毒素
  • 其他的

第八章 市场区隔：依应用领域划分

  • 感染疾病
  • 癌症
  • 过敏
  • 其他的

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Bio-Med（P）Limited
    • Daiichi Sankyo Company Limited
    • GSK plc
    • Indian Immunologicals Limited
    • Merck & Co. Inc.
    • Panacea Biotec
    • Pfizer Inc.
    • Sanofi
Product Code: SR112026A6230

The global pediatric vaccines market size reached USD 42.4 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 75.1 Billion by 2034 , exhibiting a growth rate (CAGR) of 6.35% during 2026-2034 . The growing conduction of vaccination programs, increasing focus on combination vaccines, and rising partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are some of the major factors propelling the market.

Pediatric vaccines are medical preparations that stimulate the immune system to recognize and fight specific infectious agents, such as bacteria or viruses. They comprise weakened or inactivated forms of the pathogens, or components of the pathogens, which prompt the immune system to develop a defense mechanism against the targeted disease. They provide protection from measles, polio, pertussis (whooping cough), hepatitis, and influenza. They undergo rigorous testing and evaluation to ensure their safety before being approved for use. They prevent the spread of diseases that can cause severe complications or death in children.

At present, the increasing occurrence of various infectious and potentially life-threatening diseases, such as polio, tuberculosis (TB), and malaria among children, is impelling the growth of the market. Besides this, rising government initiatives around the world aimed at immunizing children against preventable diseases are contributing to the growth of the market. In addition, the growing technological advancements in vaccine storage and distribution methods for improving the supply chain in regions where medical infrastructure may be less developed are offering a favorable market outlook. Apart from this, increasing partnerships between pharmaceutical companies and healthcare organizations for fast-tracking the development and distribution of vaccines are supporting the growth of the market. Additionally, the rising construction of clinics and hospitals around the world to improve healthcare services is bolstering the growth of the market.

PEDIATRIC VACCINES MARKET TRENDS/DRIVERS:

Growing conduction of vaccination programs

The increasing implementation of vaccination programs is notably bolstering the pediatric vaccines market. These vaccination initiatives, supported by governmental and non-governmental organizations, play a pivotal role in safeguarding the health and well-being of children. As more children receive essential immunizations against various diseases, the demand for pediatric vaccines experiences a proportional rise. Besides this, vaccination programs, with their focus on disease prevention, are decreasing the incidence of targeted illnesses among children. This subsequently translates into a reduced burden on healthcare systems and families, thereby enhancing the overall quality of life for children and their caregivers. Furthermore, the growing awareness among parents and healthcare providers about the importance of immunizations is rising the vaccine uptake rates.

Increasing focus on combination vaccines

The heightened emphasis on combination vaccines is contributing to the positive evolution of the pediatric vaccines market. Combination vaccines offer a strategic approach to immunization by providing protection against multiple diseases in a single formulation. This approach simplifies the vaccination process for healthcare providers, caregivers, and children alike, resulting in improved compliance and vaccine coverage rates. Moreover, combination vaccines address the challenges of vaccine hesitancy and the possibility of missed doses. As children receive protection against multiple diseases with one injection, the perceived burden of vaccinations is significantly reduced. This encourages parents to adhere to recommended vaccination schedules and contributes to achieving higher rates of full immunization coverage.

Rising development of novel vaccines

The increasing development of novel vaccines is playing a pivotal role in driving positive growth within the pediatric vaccines market. The emergence of new vaccines tailored specifically for the health needs of children contributes to enhanced disease prevention, improved public health outcomes, and expanded market opportunities. The development of novel vaccines also reflects advancements in vaccine technology and research. Cutting-edge research methodologies, such as genomics and bioinformatics, enable scientists to identify potential vaccine candidates more rapidly and accurately. This accelerated pace of discovery is creating vaccines that are efficacious and align with the evolving epidemiological landscape. Furthermore, the rising development of novel vaccines is stimulating collaboration between public health organizations, research institutions, and vaccine manufacturers. These partnerships facilitate the timely introduction of new vaccines and ensure their efficient distribution to the pediatric population.

PEDIATRIC VACCINES INDUSTRY SEGMENTATION:

Breakup by Type:

  • Multivalent
  • Monovalent

Multivalent dominates the market

Multivalent pediatric vaccines refer to immunization formulations that provide protection against multiple diseases through a single vaccine injection. These vaccines are designed to target two or more different disease-causing agents, such as viruses or bacteria, in a single formulation. Multivalent pediatric vaccines streamline the vaccination process by offering protection against multiple diseases with a single injection. This eliminates the need for multiple shots, reducing discomfort for children and simplifying the vaccination schedule for healthcare providers and caregivers. Multivalent pediatric vaccines optimize healthcare resources by combining multiple vaccines into a single formulation. This can result in cost savings for healthcare systems and reduce the logistical challenges associated with administering separate vaccines.

Breakup by Technology:

  • Conjugate
  • Live Attenuated
  • Inactivated
  • Subunit
  • Toxoid
  • Others

Conjugate holds the largest share in the market

Conjugate vaccines are a type of immunization that enhances the immune response against certain bacteria that have a protective polysaccharide outer coating. These vaccines work by linking or conjugating the bacterial polysaccharides to a carrier protein, creating a complex that stimulates a stronger and more effective immune response, especially in young children whose immune systems might not respond well to polysaccharides alone. Conjugate vaccines not only protect vaccinated individuals but can also reduce the carriage of bacteria in the population. This indirectly limits the spread of bacteria among both vaccinated and unvaccinated individuals. Conjugate vaccines contribute to herd immunity, which is essential for the prevention of the spreading of various infectious diseases among unvaccinated individuals.

Breakup by Application:

  • Infectious Disease
  • Cancer
  • Allergy
  • Others

Pediatric vaccines play a crucial role in preventing infectious diseases among children. By providing immunity against harmful pathogens, vaccines contribute to the health and well-being of children and infants. These vaccines are carefully developed based on scientific examination and clinical trials to ensure their safety and effectiveness.

Pediatric vaccines for cancer aim to prevent certain types of cancers that primarily affect children. They target certain infections, such as human papillomavirus (HPV) and hepatitis B virus (HBV) and are known to increase the risk of developing cancer. Besides this, administering vaccines during childhood allows for early prevention of cancer-related infections. This early intervention aligns with a proactive health approach, reducing the risk of cancer development later in life.

Pediatric vaccines play a crucial role in preventing a range of allergies among children. By bolstering the response of the immune system, vaccines help mitigate the risk of developing allergies to common allergens like pollen, dust, and pet dander.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest pediatric vaccines market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region due to the rising investment in research operations for the development of various novel vaccines for the prevention of infectious and chronic diseases. Besides this, the increasing awareness among parents and caregivers about the importance of immunization is propelling the growth of the market. Apart from this, rising improvements in the healthcare infrastructure to provide quality treatment and other healthcare facilities to individuals are supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the increasing occurrence of infectious diseases caused by various novel viruses. Besides this, rising initiatives taken by governing agencies and regulatory bodies to promote the significance of vaccination in children are bolstering the growth of the market.

COMPETITIVE LANDSCAPE:

Key market players are diligently focused on enhancing their business strategies by consistently investing in research operations to formulate innovative vaccines that cater to evolving healthcare needs. They are fostering collaborations with research institutions and regulatory bodies to ensure the safety and efficacy of their products. Leading companies are strengthening their supply chain management and distribution networks to ensure timely availability of vaccines. Furthermore, top industry players are actively engaging in educational initiatives to increase awareness about the importance of vaccination, fostering trust and credibility within the community. This concerted effort to innovate, collaborate, and educate showcases their commitment to advancing the field of pediatric vaccines and contributing to public health on a global scale.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Bio-Med (P) Limited
  • Daiichi Sankyo Company Limited
  • GSK plc
  • Indian Immunologicals Limited
  • Merck & Co. Inc.
  • Panacea Biotec
  • Pfizer Inc.
  • Sanofi

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global pediatric vaccines market in 2025?

2. What is the expected growth rate of the global pediatric vaccines market during 2026-2034?

3. What are the key factors driving the global pediatric vaccines market?

4. What has been the impact of COVID-19 on the global pediatric vaccines market?

5. What is the breakup of the global pediatric vaccines market based on the type?

6. What is the breakup of the global pediatric vaccines market based on the technology?

7. What are the key regions in the global pediatric vaccines market?

8. Who are the key players/companies in the global pediatric vaccines market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pediatric Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Multivalent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Monovalent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Conjugate
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Live Attenuated
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inactivated
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subunit
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Toxoid
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Allergy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Bio-Med (P) Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Daiichi Sankyo Company Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 GSK plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Indian Immunologicals Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Merck & Co. Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Panacea Biotec
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Pfizer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sanofi
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Pediatric Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Pediatric Vaccines Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Pediatric Vaccines Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Pediatric Vaccines Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Pediatric Vaccines Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Pediatric Vaccines Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Pediatric Vaccines Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Pediatric Vaccines (Multivalent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Pediatric Vaccines (Multivalent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Pediatric Vaccines (Monovalent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Pediatric Vaccines (Monovalent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Pediatric Vaccines (Conjugate) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Pediatric Vaccines (Conjugate) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Pediatric Vaccines (Live Attenuated) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Pediatric Vaccines (Live Attenuated) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Pediatric Vaccines (Inactivated) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Pediatric Vaccines (Inactivated) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Pediatric Vaccines (Subunit) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Pediatric Vaccines (Subunit) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Pediatric Vaccines (Toxoid) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Pediatric Vaccines (Toxoid) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Pediatric Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Pediatric Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Pediatric Vaccines (Infectious Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Pediatric Vaccines (Infectious Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Pediatric Vaccines (Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Pediatric Vaccines (Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Pediatric Vaccines (Allergy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Pediatric Vaccines (Allergy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Pediatric Vaccines (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Pediatric Vaccines (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Pediatric Vaccines Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Pediatric Vaccines Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Pediatric Vaccines Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Pediatric Vaccines Industry: SWOT Analysis
  • Figure 82: Global: Pediatric Vaccines Industry: Value Chain Analysis
  • Figure 83: Global: Pediatric Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pediatric Vaccines Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Pediatric Vaccines Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Pediatric Vaccines Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Pediatric Vaccines Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Pediatric Vaccines Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Pediatric Vaccines Market: Competitive Structure
  • Table 7: Global: Pediatric Vaccines Market: Key Players